Sentences with phrase «made by drug»

Then there also are certain oral contraceptive pills which change the hormonal balance of the body, thereby leading to irregular menstruation until the body gets accustomed to the changes made by the drug.
In addition to unwanted additives, sometimes even sugar, they typically contain low - quality synthetic vitamins made by drug companies.
What most people know as «vitamin C» is actually industrially produced synthetic ascorbic acid — made by drug companies.
Since there is no money to be made by drug companies, I doubt there will ever be more than antidotial studies on the benefits, unfortunately for many mothers who would have benefited.
That medicine made by drug giant Merck (NYSE: MRK) showed some new results today in lung cancer that are being called unprecedented.

Not exact matches

A fortune is made and spent on drugs to treat medical conditions — from stomach ulcers to headaches — that are caused or aggravated by stress.
Made by companies like Gilead, AbbVie, Merck, and others, drugs that treat the disease are listed at tens of thousands of dollars in the U.S..
In particular, the complaint alleges that throughout the Class Period, defendants made materially false and / or misleading statements and / or failed to disclose that (1) the trials for GED - 0301 suffered from fatal design defects, such that GED - 0301 had failed to demonstrate meaningful clinical efficacy; (2) the growth of Otezla sales had dramatically slowed during Celgene's third fiscal quarter of 2017; and (3) the clinical and nonclinical pharmacology data in Celgene's new drug application («NDA») for Ozanimod were insufficient to permit a complete review by the FDA, which resulted in the FDA issuing a refusal to file letter to Celgene regarding the NDA.
While the tax bill has been promoted by Republicans as a job creator, the reality is that drug companies are more likely to return the money to shareholders, or use it to make acquisitions.
In adopting its Cannabis Equity Program, the City of Oakland made a clear commitment to ensure access and equity in legal cannabis for communities most negatively impacted by the drug war.
There are actually a few of those drugs now: Cervarix, made by GSK, which targets strains 16 and 18; Gardasil, made by Merck, which preempts those two killers, plus strains 6 and 11; and Merck's Gardasil 9, which primes the body's immune system to create protective antibodies against — you guessed it — nine types of HPV.
But a nonprofit is making its own hepatitis C combination medication that it says is just as effective as those created by for - profit drug giants.
These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
Cars, fashion, television, and movies make the most appearances, followed by technology, alcohol, music, and drugs.
Celgene's patents likely won't be challenged by its rivals anytime soon — its three main patents expire in the 2020s, by which point the company will have made a considerable amount of money on the drugs.
However, it's far simpler to do consistent, smaller price hikes on drugs used by a far greater number of people in order to make up for revenue gaps.
That has been my initial impression of a new drug - delivery system, called the Medici, which is made by Intarcia Therapeutics.
Other proposals would make it easier for competing, «biosimilar» alternatives to break through the thicket of patents created by sellers of complex drugs such as insulin.
«This relationship will insulate Mexican TCOs from direct ties to street - level drug and money seizures and drug - related arrests made by US law enforcement.»
Slavitt said EpiPen has patent protection, has no Food and Drug Administration - approved equivalents, and was approved by that agency under a «new drug application,» all of which make it a brand - name dDrug Administration - approved equivalents, and was approved by that agency under a «new drug application,» all of which make it a brand - name ddrug application,» all of which make it a brand - name drugdrug.
Many investors worry that Gilead can't hope to replicate 2014's breakneck pace of revenue growth (driven largely by Sovaldi, which racked up $ 2 billion in sales in its first three months, making it the fastest - selling drug in history).
He points out a couple factors that make it hard to assign blame when it comes to the opioid epidemic — pain meds are lawful drugs, approved and regulated by the federal government, and there are «a whole lot of intermediaries: in the distribution process.
Cost - cutting by health insurers and concerns over drug pricing have made CVS's pharma - benefits unit seem like a liability to some investors; and in the head - to - head fight, Walgreens has grabbed some market share.
«The data makes it clear that ending the War on Drugs will not alone end mass incarceration, but that the federal government and some states have effectively reduced their incarcerated populations by turning to drug policy reform,» the report says.
Though it's not a perfect treatment, Eli Lilly's solanezumab — a drug 15 years in the making — will pass muster in clinical tests and be well on its way to FDA approval, as a therapy for mild Alzheimer's, by year's end.
And he built on that concept on Thursday, announcing that his firm will bolster its patient assistance programs for more than 40 drugs, including by helping people who make up to four times the federal poverty level buy their treatments for free.
The movie industry estimates that in Mexico, for every DVD sold legally, another 10 are pirated, often by notorious and dangerous drug cartels who are making a name for themselves in media piracy.
Kocher speculates that Amazon could reduce costs by accepting lower margins than pharmacy benefits managers — intermediaries that now make huge profits through sales of generic drugs in particular.
Since biosimilars are so new to the U.S. market (there have been just five total approved here since 2015), it's been hard to gauge whether or not they can make a formidable dent in high drug prices by offering generic alternatives to branded treatments.
Because, you see, Loblaws — arguably one of most skilful retailers Canada has ever produced — has announced that they think maybe the way to improve the drug store experience is by making dinner for us.
The comments, made at a conference organized by a leading U.S. health insurer lobbying group, stoked speculation over what steps the administration of U.S. President Donald Trump may take to rein in lofty prescription drug costs.
Two older mainstays among multiple - sclerosis drugs, made by other companies, have increased prices to seven times their 1990s levels to catch up with the prices of newcomers, researchers reported in April in the journal Neurology.
But the two drugs made by Regeneron and partner Sanofi as well as by Amgen (NASDAQ: AMGN) have been commercial flops.
Valeant has said its interest in working closely with a specialty pharmacy to make its drugs available to patients was based on a pilot program run by Medicis before it was acquired.
Mainz - based BioNTech has yet to make a profit and has been bankrolled for the past decade by majority owners Thomas and Andreas Struengmann, who sold their generic drugs business Hexal to Novartis (NOVN.S) in 2005.
Bayer said in a statement that it doesn't control the cost for patients at the pharmacy, because copays are determined by insurers and pharmacy - benefit managers — an argument that pharmaceuticals companies have long made when facing criticism over drug prices.
He started MSMB Capital, a hedge fund company, in his 20s and drew attention for urging the Food and Drug Administration not to approve certain drugs made by companies whose stock he was shorting.
Turing Pharmaceuticals CEO Martin Shkreli is now stating that he wishes he'd raised the price on the AIDS drug Daraprim by more than the 5000 % that made him the object of scorn worldwide.
Disclaimer: None of the statements made on this website have been reviewed by the Food and Drug Administration.
The FDA's action cuts off a vital supply line for the company, given that the plant reportedly makes about 70 % of the ingredients that Ranbaxy uses to make its U.S. drugs, including the generic version of Lipitor taken by millions of Americans.
Shoppers Drug Mart shareholders who have not made an election by the election deadline will be deemed to have elected to receive the cash consideration as to 53.9 % of their shares and the share consideration as to 46.1 % of their shares, subject to pro-ration.
Shareholders holding Shoppers Drug Mart shares through a broker, investment dealer or other intermediary, should carefully follow the instructions provided by such broker, investment dealer or other intermediary in order to make an election.
In China's health system, low salaries and skimpy budgets drive doctors, nurses and administrators to make ends meet by accepting money from patients, drug suppliers and others.
The people behind pump - and - dump shenanigans can make fast money, until they get caught: In the US, a Bugatti - driving promoter allegedly drove up the value of a prescription - drug distributor by more than $ 700 million within two months, according to a Bloomberg report.
By August, the company, which sells thousands of drugs and says it fills one in every 13 American prescriptions, was making mea culpas and renewing its promise to «do what's right, not what's easy,» as the company's mission statement goes.
On February 18th, Actavis made by far the biggest drug splash of the year when it announced that it had entered into a definitive agreement to acquire Forest Labs for a whopping $ 25 billion in cash and equity.
Market Potential You need to start by making assumptions about the drug's market potential.
The drugs industry has seen a surge in deal - making this year as large players look for promising assets to improve their pipelines, but a Takeda - Shire transaction would be by far the biggest yet.
(NB: Cocaine was, at the time, considered a wonder drug — perhaps like bitcoin in more modern times — but was eventually condemned, made illegal, and deemed an «evil» by Holmes in later works.)
Before any company can make and market even a generic pharmaceutical drug in the United States, it must be granted a special authorization by the FDA.
a b c d e f g h i j k l m n o p q r s t u v w x y z